AIM Vaccine Co., Ltd. Class H (HK:6660) has released an update.
AIM Vaccine Co., Ltd. has announced the re-designation of Mr. Jie ZHOU and Mr. Xin ZHOU from non-executive to executive Directors, as well as their appointment as executive presidents. The re-designation, effective from August 29, 2024, coincides with both individuals ceasing to be members of the audit committee and involves new service contracts without director fees. Their remuneration will be based on their new management roles, with details to be disclosed annually.
For further insights into HK:6660 stock, check out TipRanks’ Stock Analysis page.